Abstract

The influential roles of antibiotic prophylaxis on cirrhotic patients with peptic ulcer bleeding are still not well documented. The purpose of this study is to clarify these influential roles and to identify the risk factors associated with rebleeding, bacterial infection and in-hospital mortality. A cross-sectional, chart review study was conducted on 210 cirrhotic patients with acute peptic ulcer hemorrhage who underwent therapeutic endoscopic procedures. Patients were divided into group A (with prophylactic intravenous ceftriaxone, n = 74) and group B (without antibiotics, n = 136). The outcomes were length of hospital days, prevention of infection, rebleeding rate and in-hospital mortality. Our results showed that more patients suffered from rebleeding and infection in group B than group A (31.6% vs. 5.4%; p<0.001 and 25% vs. 10.8%; p = 0.014 respectively). The risk factors for rebleeding were active alcoholism, unit of blood transfusion, Rockall score, model for end-stage liver disease score and antibiotic prophylaxis. The risk factors for infection were active alcoholism, Child-Pugh C, Rockall score and antibiotic prophylaxis. Rockall score was the predictive factor for in-hospital mortality. In conclusions, antibiotic prophylaxis in cirrhotic patients after endoscopic interventions for acute peptic ulcer hemorrhage reduced infections and rebleeding rate but not in-hospital mortality. Rockall score was the predictive factor of in-hospital mortality.

Highlights

  • Bacterial infection is a major problem in cirrhotic patients with upper gastrointestinal bleeding (UGIB)

  • We conducted this study to clarify the influential roles of systemic antibiotic prophylaxis on cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments and identify the relevant risk factors

  • The exclusion criteria were patients with existing signs of infection on admission

Read more

Summary

Introduction

Bacterial infection is a major problem in cirrhotic patients with upper gastrointestinal bleeding (UGIB). These patients frequently present infections at admission or develop them during hospitalization [1,2,3]. Studies that clarify the effect antibiotic prophylaxis in cirrhotic patients with peptic ulcers bleeding alone are rare. 30 to 40% of cirrhotic patients who bleed may have nonvariceal UGIB, and frequently caused by gastroduodenal ulcers [12]. We conducted this study to clarify the influential roles of systemic antibiotic prophylaxis on cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments and identify the relevant risk factors. It was reported that intravenous ceftriaxone is more effective than fluoroquinolone in areas of a high prevalence of quinolone-resistant organisms [13]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call